3192 - PSA and PSMA Kinetics for Intermediate Risk, High- Very High Risk and Oligometastatic Prostate Cancer Patients Treated by Moderate Hypofractionated Radiotherapy (MHRT) and SBRT with Androgen Deprivation Therapy (ADT): A Single Center Prospective Database